Frailty
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Those who are visitting outpatient clinic of locomo-Frail or orthopedics 2) Men and women over 65 years old 3) Those who can walk to the hospital by themselves (Canes are allowed.) 4) Those who meet the physical activity items of the J-CHS standards or Those who meet at least 2 items in the J-CHS criteria 5) Those who have agreed to participate in this study
Exclusion criteria
Exclusion criteria: 1) Persons with implantable electronic devices (e.g., pacemakers) 2) Persons with suspected dementia (MMSE-J score of 23 or less) and no support person to operate and manage the ZB-SES 3) Those who are scheduled to receive additional rehabilitation interventions during the study period 4) Those who are participating in other intervention studies 5) Those within 6 months after artificial joint surgery 6) Those who are deemed inappropriate for inclusion in the study by the principal investigator or co-investigator 7) Persons with skin diseases or wounds at the site where the belt electrodes are applied 8) Persons with malignant neoplasms or other diseases that may affect the efficacy and safety evaluation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SPPB | — |
Secondary
| Measure | Time frame |
|---|---|
| Physical function evaluation: SPPB(Day22) Isometric knee extensor strength(Day22,Day43) Gait indices of WalkWay, a seat-type lower limb load meter: gait speed, stride length Stand-up indices of the zaRitz motor function analyzer: F/W, RFD/W, Vx/ Vw Single-leg standing time with eyes open TUG Grip strength Locomotive syndrome risk test (stand-up test, two-step test, 25-question geriatric locomotive function scale) Body composition evaluation (BIA method): Limb skeletal muscle mass, SMI, Phase Angle Imaging evaluation (skeletal muscle evaluation by CT of the mid-thigh): muscle cross-sectional area, CT value, muscle to fat ratio,Muscle and Fat Percentage Frailty assessment: J-CHS, Kihon Checklist Geriatric Depression Scale-15 (GDS15) Safety evaluation: biochemical tests (CK), immunoserology tests (CRP) | — |
Contacts
National Center for Geriatrics and Gerontology